Synthetic Blood Substitutes And Blood Products Market Explained: What Is Fueling Growth To $15.7 Billion By 2030?

Synthetic Blood Substitutes And Blood Products Market Report

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Synthetic Blood Substitutes And Blood Products Market Revenue Outlook: What CAGR Lies Ahead Through 2030?

The market for synthetic blood substitutes and blood products has witnessed rapid expansion in recent years. This market is projected to expand from $7.6 billion in 2025 to $8.81 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.9%. The historic period’s growth can be attributed to several factors including blood donation shortages, the demand arising from trauma and surgery, risks associated with transfusion-transmitted infections, an increase in cardiovascular surgeries, and military medical requirements.

The synthetic blood substitutes and blood products market is projected for substantial expansion in the coming years, with its size expected to reach $15.7 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.6%. This anticipated growth is influenced by rising trauma cases, surgeries performed on an aging population, innovations in recombinant factors, the demand for universal blood substitutes, and investments in emergency preparedness. Throughout this forecast period, significant trends will include the development of oxygen-carrying blood substitutes, alternatives for emergency trauma, a reduction in dependence on donor blood, the introduction of extended shelf-life blood products, and their adoption in military and disaster medicine.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=36534855&type=smp&name=Synthetic%20Blood%20Substitutes%20And%20Blood%20Products%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Synthetic Blood Substitutes And Blood Products Market Growth Momentum: What Factors Are Shaping Demand?

The increasing occurrence of long-term health conditions is anticipated to fuel the expansion of the synthetic blood substitutes and blood products market in the future. Chronic diseases are defined as enduring health issues that can be managed but not cured, often lasting over a year and requiring continuous medical attention. This surge in chronic disease prevalence stems from various factors, such as an aging demographic, unhealthy habits, and extended lifespans. Synthetic blood substitutes and blood products are crucial for managing chronic disease prevalence, as they tackle specific issues like blood loss, anemia, and organ dysfunction, frequently observed in individuals with chronic ailments. For example, data from March 2025, provided by the Office for Health Improvement & Disparities (OHID), a UK unit of the Department of Health and Social Care, showed that the prevalence of type 2 diabetes recorded by GPs in adults aged 17 and over in England was 7.0% in March 2024, marking an increase from 6.8% in March 2023. Consequently, the growing incidence of chronic diseases acts as a significant catalyst for the expansion of the synthetic blood substitutes and blood products market.

Synthetic Blood Substitutes And Blood Products Market Segment Performance And Emerging Opportunities

The synthetic blood substitutes and blood products market covered in this report is segmented –

1) By Type: Perfluorocarbon Based Product (PFC), Haemoglobin Based Oxygen Carrier, Synthetic Platelet, Recombinant Factor, Blood Expander

2) By Application: Cardiovascular Diseases, Anaemia, Organ Transplant, Injury and Trauma, Other Applications

3) By End-User: Hospitals And Clinics, Blood Banks, Other End users

Subsegments:

1) By Perfluorocarbon Based Product (PFC): Emulsion-Based Products, Non-Emulsion-Based Products

2) By Haemoglobin Based Oxygen Carrier: Polymerized Hemoglobin-Based Products, Crosslinked Hemoglobin-Based Products

3) By Synthetic Platelet: Platelet Substitutes, Platelet Aggregation Inhibitors

4) By Recombinant Factor: Recombinant Factor VIII, Recombinant Factor IX, Other Recombinant Factors

5) By Blood Expander: Colloid Solutions, Crystalloid Solutions

Synthetic Blood Substitutes And Blood Products Market Trends Redefining Industry Growth

Leading companies active in the synthetic blood substitutes and blood products market are concentrating on developing innovative products, such as lab-grown blood vessels. This focus aims to enhance emergency medical care, improve outcomes for trauma treatment, and address the global scarcity of donor blood and tissues. Lab-grown blood vessels are artificial blood conduits engineered from human or synthetic cells, designed to emulate the structure and function of natural arteries and veins for medical uses like trauma repair, dialysis, and cardiovascular surgery. For instance, in December 2024, Humacyte Global, Inc., a US-based clinical-stage biotechnology platform company, received US Food and Drug Administration (FDA) approval for Symvess. This off-the-shelf, bioengineered blood vessel implant is intended for trauma patients needing urgent revascularization, providing a safer option than vein harvesting or synthetic grafts. Symvess, developed for universal application, functions by restoring blood flow and preserving limbs after severe injuries.

Synthetic Blood Substitutes And Blood Products Market Competitive Analysis Of Leading Industry Participants

Major companies operating in the synthetic blood substitutes and blood products market are Takeda Pharmaceutical Company Limited, Fresenius Kabi AG, Baxter International Inc., Octapharma AG, Green Cross Corporation, Alliance Pharmaceutical Corporation, Hemosol Inc., Sanguine Corporation, Sangart Inc., Biopure Corporation, Tenex Therapeutics, Velico Medical, Hemarina S.A., KaloCyte Inc., Aurum Biosciences Limited, SpheriTech Limited, Dendritech Inc., HbO2 Therapeutics LLC, HemoBioTech Inc., Somatogen Inc.

View The Full Synthetic Blood Substitutes And Blood Products Market Report:

https://thebusinessresearchcompany.com/report/synthetic-blood-substitutes-and-blood-products-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Synthetic Blood Substitutes And Blood Products Market Geographic Distribution And Regional Opportunities

North America was the largest region in the synthetic blood substitutes and blood products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic blood substitutes and blood products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model